These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 17141951)
1. Sensitization of chronic lymphocytic leukemia cells to TRAIL-induced apoptosis by hyperthermia. Moulin M; Dumontet C; Arrigo AP Cancer Lett; 2007 May; 250(1):117-27. PubMed ID: 17141951 [TBL] [Abstract][Full Text] [Related]
2. Long lasting heat shock stimulation of TRAIL-induced apoptosis in transformed T lymphocytes. Moulin M; Arrigo AP Exp Cell Res; 2006 Jun; 312(10):1765-84. PubMed ID: 16584728 [TBL] [Abstract][Full Text] [Related]
3. Aberrant expression of TRAIL in B chronic lymphocytic leukemia (B-CLL) cells. Secchiero P; Tiribelli M; Barbarotto E; Celeghini C; Michelutti A; Masolini P; Fanin R; Zauli G J Cell Physiol; 2005 Nov; 205(2):246-52. PubMed ID: 15887227 [TBL] [Abstract][Full Text] [Related]
4. Valproic acid induces apoptosis in chronic lymphocytic leukemia cells through activation of the death receptor pathway and potentiates TRAIL response. Lagneaux L; Gillet N; Stamatopoulos B; Delforge A; Dejeneffe M; Massy M; Meuleman N; Kentos A; Martiat P; Willems L; Bron D Exp Hematol; 2007 Oct; 35(10):1527-37. PubMed ID: 17697742 [TBL] [Abstract][Full Text] [Related]
5. Targeting pro-apoptotic trail receptors sensitizes HeLa cervical cancer cells to irradiation-induced apoptosis. Maduro JH; de Vries EG; Meersma GJ; Hougardy BM; van der Zee AG; de Jong S Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):543-52. PubMed ID: 18793956 [TBL] [Abstract][Full Text] [Related]
6. Phytosphingosine in combination with TRAIL sensitizes cancer cells to TRAIL through synergistic up-regulation of DR4 and DR5. Choi SY; Kim MJ; Chung HY; Lee SJ; Jang YJ Oncol Rep; 2007 Jan; 17(1):175-84. PubMed ID: 17143496 [TBL] [Abstract][Full Text] [Related]
8. Effect of hyperthermia on TRAIL-induced apoptotic death in human colon cancer cells: development of a novel strategy for regional therapy. Yoo J; Lee YJ J Cell Biochem; 2007 Jun; 101(3):619-30. PubMed ID: 17212362 [TBL] [Abstract][Full Text] [Related]
9. Dexamethasone counteracts the anti-osteoclastic, but not the anti-leukemic, activity of TNF-related apoptosis inducing ligand (TRAIL). Zauli G; Rimondi E; Celeghini C; Milani D; Secchiero P J Cell Physiol; 2010 Feb; 222(2):357-64. PubMed ID: 19877156 [TBL] [Abstract][Full Text] [Related]
10. A novel paradigm to trigger apoptosis in chronic lymphocytic leukemia. Loeder S; Zenz T; Schnaiter A; Mertens D; Winkler D; Döhner H; Debatin KM; Stilgenbauer S; Fulda S Cancer Res; 2009 Dec; 69(23):8977-86. PubMed ID: 19920200 [TBL] [Abstract][Full Text] [Related]
13. The expression of TRAIL and its receptors in gastric cancer and the apoptotic effect of rh-TRAIL on SGC7901 cells. Hu JK; Yang K; Li CM; Zhang B; Chen ZX; Chen XZ; Chen JP Oncol Rep; 2009 Mar; 21(3):681-8. PubMed ID: 19212626 [TBL] [Abstract][Full Text] [Related]
14. Rosiglitazone promotes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by reactive oxygen species-mediated up-regulation of death receptor 5 and down-regulation of c-FLIP. Kim YH; Jung EM; Lee TJ; Kim SH; Choi YH; Park JW; Park JW; Choi KS; Kwon TK Free Radic Biol Med; 2008 Mar; 44(6):1055-68. PubMed ID: 18164688 [TBL] [Abstract][Full Text] [Related]
15. The proteasome inhibitor PS-341 (bortezomib) up-regulates DR5 expression leading to induction of apoptosis and enhancement of TRAIL-induced apoptosis despite up-regulation of c-FLIP and survivin expression in human NSCLC cells. Liu X; Yue P; Chen S; Hu L; Lonial S; Khuri FR; Sun SY Cancer Res; 2007 May; 67(10):4981-8. PubMed ID: 17510429 [TBL] [Abstract][Full Text] [Related]
16. Sensitization of human K562 leukemic cells to TRAIL-induced apoptosis by inhibiting the DNA-PKcs/Akt-mediated cell survival pathway. Kim MJ; Kim HB; Bae JH; Lee JW; Park SJ; Kim DW; Park SI; Kang CD; Kim SH Biochem Pharmacol; 2009 Sep; 78(6):573-82. PubMed ID: 19464267 [TBL] [Abstract][Full Text] [Related]
17. Generation of new TRAIL mutants DR5-A and DR5-B with improved selectivity to death receptor 5. Gasparian ME; Chernyak BV; Dolgikh DA; Yagolovich AV; Popova EN; Sycheva AM; Moshkovskii SA; Kirpichnikov MP Apoptosis; 2009 Jun; 14(6):778-87. PubMed ID: 19412666 [TBL] [Abstract][Full Text] [Related]
18. TRAIL resistance of breast cancer cells is associated with constitutive endocytosis of death receptors 4 and 5. Zhang Y; Zhang B Mol Cancer Res; 2008 Dec; 6(12):1861-71. PubMed ID: 19074831 [TBL] [Abstract][Full Text] [Related]
19. Sensitization of mesothelioma cells to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by heat stress via the inhibition of the 3-phosphoinositide-dependent kinase 1/Akt pathway. Pespeni MH; Hodnett M; Abayasiriwardana KS; Roux J; Howard M; Broaddus VC; Pittet JF Cancer Res; 2007 Mar; 67(6):2865-71. PubMed ID: 17363610 [TBL] [Abstract][Full Text] [Related]
20. Arsenic trioxide sensitizes human glioma cells, but not normal astrocytes, to TRAIL-induced apoptosis via CCAAT/enhancer-binding protein homologous protein-dependent DR5 up-regulation. Kim EH; Yoon MJ; Kim SU; Kwon TK; Sohn S; Choi KS Cancer Res; 2008 Jan; 68(1):266-75. PubMed ID: 18172319 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]